Literature DB >> 25492509

Is less more: does leukopenia predict remission in patients with inflammatory bowel disease receiving thiopurine treatment?

Javier P Gisbert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25492509     DOI： 10.1007/s10620-014-3481-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Significance of WBC differential when leukopenia is induced by 6-MP for IBD.

Authors:  B I Korelitz; J Zlatanic; M J Smith; R J Lipe; P J Baiocco; G W Gleim
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

2.  Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.

Authors:  Mi Sung Park; Dong Hyun Kim; Duk Hwan Kim; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Dig Dis Sci       Date:  2014-09-20       Impact factor: 3.199

3.  The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.

Authors:  T Colonna; B I Korelitz
Journal:  Am J Gastroenterol       Date:  1994-03       Impact factor: 10.864

4.  Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?

Authors:  S Campbell; S Ghosh
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-09       Impact factor: 2.566

Review 5.  Neutropenia is not required for clinical remission during azathioprine therapy in inflammatory bowel disease.

Authors:  K M Persley; D H Present
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-09       Impact factor: 2.566

6.  Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.

Authors:  J Belaiche; J P Desager; Y Horsmans; E Louis
Journal:  Scand J Gastroenterol       Date:  2001-01       Impact factor: 2.423

Review 7.  [Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity].

Authors:  J P Gisbert; F Gomollón; J Maté; J M Pajares
Journal:  Rev Clin Esp       Date:  2002-10       Impact factor: 1.556

Review 8.  Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review.

Authors:  Javier P Gisbert; Fernando Gomollón
Journal:  Am J Gastroenterol       Date:  2008-06-28       Impact factor: 10.864

Review 9.  Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.

Authors:  Eliza Prefontaine; Lloyd R Sutherland; John K Macdonald; Monica Cepoiu
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

10.  Thiopurine methyltransferase activity in Spain: a study of 14,545 patients.

Authors:  Javier P Gisbert; Fernando Gomollón; Carlos Cara; Marta Luna; Yago González-Lama; José María Pajares; José Maté; Luis G Guijarro
Journal:  Dig Dis Sci       Date:  2007-03-02       Impact factor: 3.487
View more
  1 in total

Review 1.  Monitoring thiopurine metabolites in inflammatory bowel disease.

Authors:  Yago González-Lama; Javier P Gisbert
Journal:  Frontline Gastroenterol       Date:  2016-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.